Melvin Hay is an experienced financial professional currently serving as Financial Controller at Piramal Enterprises Limited since January 2017, with responsibilities focused on Piramal Critical Care. Prior to this role, Melvin held various positions at Teva Pharmaceuticals from March 2008 to December 2016, including Director of Business Planning & Analysis and Plant Controller, where financial leadership supported a manufacturing operation with annual sales exceeding $500 million. Melvin's earlier experience includes significant roles at Air Products and Chemicals from April 1985 to March 2008, managing accounting operations across multiple manufacturing businesses and driving strategic initiatives to reduce operating costs. Melvin began a career at Ernst and Young as a Senior Accountant/Auditor from May 1982 to April 1985. Melvin holds an MBA in Management & Economics from Lehigh University and a BS in Accounting from The Pennsylvania State University.